Brief: Medigene Sells Remaining Shares In Immunocore

Medigene AG

01/09/2021 06:37

Sept 1 (Reuters) - MEDIGENE AG  MDG1k.DE :
    * MEDIGENE EXTENDS CASH REACH INTO Q1 OF 2023
    * SOLD ALL OF ITS REMAINING SHARES IN IMMUNOCORE HOLDINGS
LTD.
(IMMUNOCORE), CONSISTING OF 162,035 ORDINARY SHARES, NET OF
TRANSACTION COSTS FOR APPROX. US-USD4.7 MILLION

Source text for Eikon:  ID:nPex1nGpra 
Further company coverage:  MDG1k.DE 

 (Gdansk Newsroom)
 ((Gdansk.Newsroom@thomsonreuters.com;))